Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-30

Clinical Trial Update: Argus® II Retinal Stimulation System Feasibility Protocol [NA]

View source ↗

Summary

A completed feasibility protocol study for the Argus II retinal stimulation system in retinitis pigmentosa with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Argus II Retinal Stimulation System (electronic implant retinal prosthesis)

Snippet

Sponsor: Second Sight Medical Products | Conditions: Retinitis Pigmentosa | NA | Status: COMPLETED | Results posted: 2021-12-30